FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

R. Boellaard, M.J. O'Doherty, W.A. Weber, F.M. Mottaghy, M.N. Lonsdale, S.G. Stroobants, W.J.G. Oyen, J. Kotzerke, O.S. Hoekstra, J. Pruim, P.K. Marsden, K. Tatsch, C.J. Hoekstra, E.P. Visser, B. Arends, F.J. Verzijlbergen, J.M. Zijlstra, E.F.I. Comans, A.A. Lammertsma, A.M. Paans, A.T. Willemsen, T. Beyer, A. Bockisch, C. Schaefer-Prokop, D. Delbeke, R.P. Baum, A. Chiti and B.J. Krause

European Journal of Nuclear Medicine and Molecular Imaging 2010;37:181-200



The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will therefore address general information about[18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out,interpret, and document quantitative FDG PET/CT examinations,but will concentrate on the optimisation of diagnostic quality and quantitative information.